How can small and mid-sized pharmaceutical companies effectively prioritize and leverage medical affairs strategies? Join this Xtalks webinar for an insightful discussion with our experts as they delve into the art and science of early medical affairs engagement. Register here: From Insight to Impact: https://ow.ly/7Bsx30sEIb8 #SyneosHealth ft. Anshu Sawhney, Dr. Diego Grauman
Puja Merchant’s Post
More Relevant Posts
-
Cancer is a rare condition in children, with just over 15,000 cases diagnosed each year in the US, but it remains the leading cause of death by disease among children after infancy. Learn more from our experts about the future of childhood cancers: https://ow.ly/ZSQR30sEOPn #SyneosHealth
-
-
#ICYMI: Watch our full webinar recording to explore how medical affairs is uniquely positioned to infuse drug development with the voice of the patient and bring scientific information with patient communities that benefit all: https://ow.ly/x3V830sEOPm #SyneosHealth
-
-
In case you missed #SyneosHealth at the Financial Times Live: Funding Biopharma Innovation event in New York City, watch the full recording here for insights from Bicycle Therapeutics, Deerfield Management, Obvious Ventures and Rising Pharmaceuticals: https://lnkd.in/eRFcWVuu #SyneosHealthLife #WorkHereMattersEverywhere #ClinicalCareers
-
-
At Syneos Health, we know successful site partnership is the cornerstone to advancing clinical research and diverse patient representation. We’re thrilled to collaborate with the Society for Clinical Research Sites (SCRS) to celebrate the second Site Excellence in Patient Inclusion Award recognizing clinical research sites for their commitment to diversity, equity and inclusion in clinical trials. Submit a nomination here: https://ow.ly/sURH30sEOOE #SyneosHealth #SCRS #ClinicalResearch #PatientDiveristy
-
-
Interested in receiving more content from Syneos Health straight to your inbox? Subscribe to our newsletter, The Syneos Health Weekly Sync, today! https://ow.ly/8gLq30sEIbk #SyneosHealth
-
-
There are approximately twelve times more single-country adoptive cell therapy clinical trials being run in the APAC region than in Europe. Learn more here: https://ow.ly/tyCu30sEIbi
-
-
Great Opportunity! Come connect with us to learn more about the role.
I'm thrilled to announce an incredible opportunity to join Syneos Health as a Real-World Evidence (RWE) Regulatory Lead. 🚀 This role is perfect for someone who thrives in a dynamic environment, where your expertise in both RWE and regulatory science/strategy will directly impact the success of our groundbreaking initiatives. If you're passionate about transforming healthcare through data-driven insights and regulatory excellence, we want to hear from you! Reach out to learn more about how you can contribute to our mission and make a difference in the lives of patients worldwide. Link to apply: https://lnkd.in/gtn4cd_s Amanda Bruno, Melissa Everitt, PHR, ITIL v3, Puja Merchant, Melis Yamaner
-
For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials, in an effort to diversify participation in studies of new medicines. In this article, Ramita Tandon, Walgreens’ Chief Clinical Trials Officer, shares the continued importance of this work for the company. Dive in: https://ow.ly/Y8I930sEIbl
-
-
In this PM360 article, our expert Ray Huml shares his insight on the importance of patient support programs for people living with a rare disease and how we can best listen to the voice of the patient, positively impacting those who need it most. Read the full article: https://ow.ly/NvwY30sEIb5 #SyneosHealth
-
